| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2011 | US20110173712 Enhancement of plant yield vigor and stress tolerance |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173710 Chimeric meganuclease enzymes and uses thereof |
| 07/14/2011 | US20110173706 Novel gpr101 transgenic mice and methods of use thereof |
| 07/14/2011 | US20110172406 Molecular structure of rhd negative |
| 07/14/2011 | US20110172403 Microfluidic Device Including Purification Column with Excess Diluent and Method |
| 07/14/2011 | US20110172398 Bispecific binding molecules for anti-angiogenesis therapy |
| 07/14/2011 | US20110172397 Anti-psgl-1 antibodies |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172293 Methods and Compositions for Modulating Angiogenesis |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172291 Rna interference for the treatment of gain-of-function disorders |
| 07/14/2011 | US20110172290 Isoforms of eIF-5A: Senescence-induced eIF5A; Wounding-induced elF-5A; Growth elF-5A; and DHS |
| 07/14/2011 | US20110172288 Compositions and Methods for the Identification, Assessment, Prevention and Therapy of Thymic Lymphoma or Hamartomatous Tumours |
| 07/14/2011 | US20110172287 Compositions and methods for inhibiting tumor growth and metastasis |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172168 Ilt-2 (lir1) variants with increased affinity for mhc class i molecules |
| 07/14/2011 | US20110172165 Modified linkers |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172144 Methods for increasing expression of serca2a in cardiac muscle |
| 07/14/2011 | US20110172143 Method of modulating cell survival and reagents useful for same |
| 07/14/2011 | US20110172140 Poly-Pegylated Protease Inhibitors |
| 07/14/2011 | US20110172123 Arrays |
| 07/14/2011 | US20110172120 Compositions and Systems for the Regulation of Genes |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110172113 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| 07/14/2011 | US20110171751 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi |
| 07/14/2011 | US20110171734 Conjugative plasmids and methods of use thereof |
| 07/14/2011 | US20110171733 Bovine Immunodeficiency Virus (BIV) Based Vectors |
| 07/14/2011 | US20110171728 Method and composition for crystallizing G protein-coupled receptors |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171720 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 07/14/2011 | US20110171718 Proteases With Modified Pre-Pro Regions |
| 07/14/2011 | US20110171698 C-22 hydroxylase |
| 07/14/2011 | US20110171693 Amylases, nucleic acids encoding them and methods for making and using them |
| 07/14/2011 | US20110171692 Process for amplifying dna in cells |
| 07/14/2011 | US20110171686 Reverse cumate repressor mutant |
| 07/14/2011 | US20110171675 Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same |
| 07/14/2011 | US20110171674 Beta-Glucosidase Variants Having Improved Activity, and Uses Thereof |
| 07/14/2011 | US20110171669 Isolated luciferase gene of L. ITALICA |
| 07/14/2011 | US20110171659 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/14/2011 | US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo |
| 07/14/2011 | US20110171266 Malaria vaccine |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171262 Parvoviral capsid with incorporated gly-ala repeat region |
| 07/14/2011 | US20110171260 Influenza dna vaccination and methods of use thereof |
| 07/14/2011 | US20110171257 Herpes simplex virus amplicon vectors derived from primary isolates |
| 07/14/2011 | US20110171255 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171250 Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171234 Vaccine |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171216 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171211 Heat shock protein gp96 vaccination and methods of using same |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171198 Highly functional enzyme having alpha-galactosidase activity |
| 07/14/2011 | US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 07/14/2011 | US20110171185 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110170075 Device for chemical and biochemical reactions using photo-generated reagents |
| 07/14/2011 | DE112009002061T5 Nematodenresistente transgene Pflanzen Nematode-resistant transgenic plants |
| 07/14/2011 | DE112009001976T5 Transgene Pflanzen mit erhöhtem Ertrag Transgenic plants with increased yield |
| 07/14/2011 | DE112009000934T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
| 07/14/2011 | CA2786741A1 Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
| 07/14/2011 | CA2786664A1 Vectors and methods for transducing b cells |
| 07/14/2011 | CA2786659A1 Mouse artificial chromosome vector |
| 07/14/2011 | CA2786644A1 Improved recovery of nucleic acids from magnetic glass particles |
| 07/14/2011 | CA2786545A1 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| 07/14/2011 | CA2786535A1 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
| 07/14/2011 | CA2786405A1 Methods for producing isomers of muconic acid and muconate salts |
| 07/14/2011 | CA2786377A1 Compositions and methods for treating glioblastoma gbm |
| 07/14/2011 | CA2786301A1 Herbicide-tolerant plants |
| 07/14/2011 | CA2786056A1 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 07/14/2011 | CA2785845A1 Constitutive synthetic plant promoters and methods of use |
| 07/14/2011 | CA2785631A1 Method of use of stabilized plant-derived growth factor in skin care |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2785195A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/14/2011 | CA2784970A1 Novel pneumovirus compositions and methods for using the same |
| 07/14/2011 | CA2784953A1 Humanized fc.gamma.r mice |
| 07/14/2011 | CA2784861A1 Recombinant butyrylcholinesterases and truncates thereof |
| 07/14/2011 | CA2784652A1 Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging |
| 07/14/2011 | CA2784429A1 Transgenic non-human animal and uses thereof |